DNA barcoded peptide-MHC multimers to measure and monitor minor histocompatibility antigen-specific T cells after allogeneic stem cell transplantation [PDF]
Allogeneic stem cell transplantation (alloSCT) provides a curative treatment option for hematological malignancies. After HLA-matched alloSCT, donor-derived T cells recognize minor histocompatibility antigens (MiHAs), which are polymorphic peptides ...
Sine R Hadrup +13 more
doaj +2 more sources
Prolonged Skin Graft Survival and Histocompatibility in Highly Inbred Miniature Swine [PDF]
Background. Pigs are potential organ donors for humans. Some proposed xenotransplant tolerance regimens require genetically identical cells from different animals (eg, juvenile bone marrow and mature organs or tissues).
Elin Manell, DVM, PhD +9 more
doaj +2 more sources
A uniform genomic minor histocompatibility antigen typing methodology and database designed to facilitate clinical applications. [PDF]
BACKGROUND: Minor Histocompatibility (H) antigen mismatches significantly influence the outcome of HLA-matched allogeneic stem cell transplantation. The molecular identification of human H antigens is increasing rapidly. In parallel, clinical application
Eric Spierings +6 more
doaj +2 more sources
LB-ARHGDIB-1R as a novel minor histocompatibility antigen for therapeutic application [PDF]
Margot J. Pont +11 more
doaj +2 more sources
A polymorphism in the splice donor site of ZNF419 results in the novel renal cell carcinoma-associated minor histocompatibility antigen ZAPHIR. [PDF]
Nonmyeloablative allogeneic stem cell transplantation (SCT) can induce remission in patients with renal cell carcinoma (RCC), but this graft-versus-tumor (GVT) effect is often accompanied by graft-versus-host disease (GVHD).
Kelly Broen +11 more
doaj +2 more sources
In Search of Immunodominant Minor Histocompatibility Antigens [PDF]
survival. Larger retrospective studies should parse out relapse risk in specific cytogenetic subgroups, to offer more guidance to the practicing clinician. Our hope is that this and other retrospective studies of MRD monitoring leads to an assessment of the prognostic impact of MRD in well-defined molecular and cytogenetic subsets of AML.
Claude Perreault
openalex +3 more sources
Human minor histocompatibility antigens
For over five decades minor histocompatibility (mH) antigens have contmued to fascmate immimologists, mainly because of their minor but distinct role in transplantation but no less because of their as yet unknown nature In the 1970s lt became evident that mH antigens were recognized in a MHC restncted fashion, an important feature which was poorly ...
M, de Bueger, E, Goulmy
+8 more sources
T-Cell Immunotherapies Targeting Histocompatibility and Tumor Antigens in Hematological Malignancies
Over the last decades, T-cell immunotherapy has revealed itself as a powerful, and often curative, strategy to treat blood cancers. In hematopoietic cell transplantation, most of the so-called graft-vs.-leukemia (GVL) effect hinges on the recognition of ...
Valérie Janelle +6 more
doaj +1 more source
The Connection Between Minor H Antigens and Neoantigens and the Missing Link in Their Prediction
For hundreds of thousands of years, the human genome has extensively evolved, resulting in genetic variations in almost every gene. Immunological reflections of these genetic variations become clearly visible after an allogeneic stem cell transplantation
Tuna Mutis +4 more
doaj +1 more source
Identification of minor histocompatibility antigens [PDF]
Slavoljub Milosevic
openalex +2 more sources

